Literature DB >> 18621011

Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS.

Simon Swingler1, Jin Zhou, Catherine Swingler, Ann Dauphin, Thomas Greenough, Paul Jolicoeur, Mario Stevenson.   

Abstract

B lymphocyte hyperactivation and elevated immunoglobulin levels (hypergammaglobulinemia) are pathogenic manifestations of HIV-1 infection. Here we provide evidence that these hallmarks are caused by a soluble factor whose production by infected macrophages is induced by the HIV-1 Nef protein. In vitro, HIV-1-infected macrophages or macrophages expressing Nef promoted B cell activation and differentiation to immunoglobulin-secreting cells. Nef-mediated activation of NF-kappaB in macrophages induced secretion of the acute-phase protein ferritin, and ferritin was necessary and sufficient for the observed Nef-dependent B cell changes. The extent of hypergammaglobulinemia in HIV-1-infected individuals correlated directly with plasma ferritin levels and with viral load. Furthermore, the induction of ferritin production and hypergammaglobulinemia was recapitulated when Nef was specifically expressed in macrophages and T cells of transgenic mice. Collectively, these results indicate that the HIV-1 Nef protein carries a pathogenic determinant that governs B cell defects in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621011      PMCID: PMC2911124          DOI: 10.1016/j.chom.2008.05.015

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  46 in total

1.  Identification of H- and L-ferritin subunit binding sites on human T and B lymphoid cells.

Authors:  G J Anderson; W P Faulk; P Arosio; D Moss; L W Powell; J W Halliday
Journal:  Br J Haematol       Date:  1989-10       Impact factor: 6.998

2.  Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.

Authors:  S Pahwa; R Pahwa; R A Good; R C Gallo; C Saxinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection.

Authors:  D L Jacobson; J A McCutchan; P L Spechko; I Abramson; R S Smith; A Bartok; G R Boss; D Durand; S A Bozzette; S A Spector
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

4.  HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.

Authors:  A Amadori; R Zamarchi; V Ciminale; A Del Mistro; S Siervo; A Alberti; M Colombatti; L Chieco-Bianchi
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

5.  Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection.

Authors:  J Rautonen; N Rautonen; N L Martin; R Philip; D W Wara
Journal:  AIDS       Date:  1991-11       Impact factor: 4.177

6.  Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1.

Authors:  D R Lucey; C W Hendrix; C Andrzejewski; G P Melcher; C A Butzin; R Henry; F H Wians; R N Boswell
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

7.  Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.

Authors:  A Shirai; M Cosentino; S F Leitman-Klinman; D M Klinman
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  Simultaneous detection of ferritin and HIV-1 in reactive microglia.

Authors:  M Yoshioka; P Shapshak; N C Sun; S J Nelson; A Svenningsson; L G Tate; V Pardo; L Resnick
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control.

Authors:  S Fargion; A L Fracanzani; B Brando; P Arosio; S Levi; G Fiorelli
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

10.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  37 in total

1.  A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages.

Authors:  Lue Dai; Mario Stevenson
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Intrusive HIV-1-infected cells.

Authors:  Dominika Rudnicka; Olivier Schwartz
Journal:  Nat Immunol       Date:  2009-09       Impact factor: 25.606

Review 3.  Adding new dimensions: towards an integrative understanding of HIV-1 spread.

Authors:  Oliver T Fackler; Thomas T Murooka; Andrea Imle; Thorsten R Mempel
Journal:  Nat Rev Microbiol       Date:  2014-08       Impact factor: 60.633

4.  HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.

Authors:  Bettina Stolp; Andrea Imle; Fernanda Matos Coelho; Miroslav Hons; Roser Gorina; Ruth Lyck; Jens V Stein; Oliver T Fackler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

5.  CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection.

Authors:  Rodolfo Silva; Susan Moir; Lela Kardava; Karen Debell; Venkateswara R Simhadri; Sara Ferrando-Martínez; Manuel Leal; José Peña; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2011-04-11       Impact factor: 22.113

6.  Iron Deficiency is Prevalent among HIV-Infected Kenyan Adults and is Better Measured by Soluble Transferrin Receptor than Ferritin.

Authors:  Anne E P Frosch; George Ayodo; Eliud O Odhiambo; Kathleen Ireland; John Vulule; Sarah E Cusick
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 2.345

7.  CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.

Authors:  Marta Epeldegui; Dharma R Thapa; Justin De la Cruz; Scott Kitchen; Jerome A Zack; Otoniel Martínez-Maza
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

8.  Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Authors:  Kassandre Leongson; Vincent Cousineau-Côté; Mathieu Goupil; Francine Aumont; Serge Sénéchal; Louis Gaboury; Paul Jolicoeur; James W Kronstad; Louis de Repentigny
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

Review 9.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

10.  HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.

Authors:  Weifeng Xu; Paul A Santini; John S Sullivan; Bing He; Meimei Shan; Susan C Ball; Wayne B Dyer; Thomas J Ketas; Amy Chadburn; Leona Cohen-Gould; Daniel M Knowles; April Chiu; Rogier W Sanders; Kang Chen; Andrea Cerutti
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.